Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $25.6 million.

  • Lemaitre Vascular's Operating Expenses rose 671.24% to $25.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.0 million, marking a year-over-year increase of 1358.47%. This contributed to the annual value of $98.6 million for FY2024, which is 919.67% up from last year.
  • As of Q3 2025, Lemaitre Vascular's Operating Expenses stood at $25.6 million, which was up 671.24% from $28.8 million recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Operating Expenses registered a high of $28.8 million during Q2 2025, and its lowest value of $15.7 million during Q2 2021.
  • In the last 5 years, Lemaitre Vascular's Operating Expenses had a median value of $22.6 million in 2023 and averaged $21.9 million.
  • In the last 5 years, Lemaitre Vascular's Operating Expenses tumbled by 171.11% in 2021 and then skyrocketed by 4069.63% in 2022.
  • Lemaitre Vascular's Operating Expenses (Quarter) stood at $17.7 million in 2021, then increased by 8.11% to $19.1 million in 2022, then grew by 20.81% to $23.1 million in 2023, then rose by 11.61% to $25.7 million in 2024, then decreased by 0.36% to $25.6 million in 2025.
  • Its last three reported values are $25.6 million in Q3 2025, $28.8 million for Q2 2025, and $28.8 million during Q1 2025.